Stay updated on Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    New help/navigation items were added to the study details page: How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment label formatting was adjusted and the revision tag in the footer updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T08:10:49.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision metadata on the page was updated from v3.5.4 to v3.5.5, indicating a minor update to the page versioning without altering the study information.
    Difference
    0.1%
    Check dated 2026-06-08T04:12:09.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Footer revision updated from v3.5.3 to v3.5.4, signaling a standard site version update. No visible changes to the study details or page functionality were observed.
    Difference
    0.1%
    Check dated 2026-05-17T10:30:50.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page’s revision/build identifier was updated from v3.5.2 to v3.5.3, reflecting a minor website release without changing the displayed study record.
    Difference
    0.1%
    Check dated 2026-04-25T18:45:35.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:30:13.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T00:56:04.000Z thumbnail image

Stay in the know with updates to Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.